| V |
|
Vaccinoassociated Acute Thrombocytopenic Purpura in Children
|
| Petrov V |
| |
|
Validation of a Clinical Score (CS) Plus D-Dimer (DDi) Combination As a Diagnostic Strategy to Exclude Pulmonary Embolism (PE)
|
| Bottaro F, Ceresetto JM, Finn B, Duboscq C, Rabinovich O, Stemmelin G, Shanley C, Doti C, Vicente MA, Bullorsky E |
| |
|
Validation of Laboratory Reference Standards for Clinical Use of INR-POC Devices: A Randomized Multicentre Exercise
|
| Ferrante F, Paccamiccio E, Iaboni S, Iorio A |
| |
|
Validation of Overt Disseminated Intravascular Coagulation (DIC) Scoring Algorithm Use in Critically Ill Patients: Correlation with Inflammatory Markers and APACHE and SOFA Scores
|
| Rapson D, Heyland D, Saberi F, Dwyre L, Lam M, Jones G |
| |
|
Value of D-dimer, for the Exclusion of Deep Venous Thrombosis, in Different Pre-test Clinical Probability Categories
|
| El Kheir D, Gerdes V, Büller H |
| |
|
Variation in Coagulation Inhibitors During Prolonged Sitting: Possible Pathogenetic Mechanisms for Travel-associated Thrombosis
|
| Stricker H, Colucci G, Alberio L, Haeberli A, Mombelli G |
| |
|
Vascular Complications at Patients with Polycythemia Vera: Interrelation Between Endothelial Dysfunction and Haemostasis Disorders
|
| Voznyuk V |
| |
|
Vascular Complications at Patients with Polycythemia Vera: Interrelation between Endothelial Dysfunction and Haemostasis Disorders
|
| Voznyuk V |
| |
|
Vav Family Proteins Are Required for Optimal Platelet Spreading on Fibrinogen
|
| Pearce AC, McCarty OJT, Calaminus SDJ, Turner M, Vigorito E, Watson SP |
| |
|
VCAM-1 as Target for Immunoliposome-Mediated Drug Delivery to Activated Endothelial Cells
|
| Voinea M, Dragomir E, Manduteanu I, Capraru M, Simionescu M |
| |
|
VEGF-R2 and Neuropilin-1 Are Involved in VEGF-A-Induced Differenciation of Human Bone Marrow Progenitor Cells
|
| Fons P, Hérault J-P, Delesque N, Tuyaret J, Bono F, Herbert J-M |
| |
|
Vein Abnormalities and the Post-Thrombotic Syndrome. A Prospective Study
|
| Prandoni P, Frulla M, Sartor D, Concolato A, Girolami A |
| |
|
Vein Trombosis in Pediatric Patients
|
| Colorado M, Pérez-Montes R, Batlle A, Yánez L, Sedano C, Iriondo A |
| |
|
Venous Function and Clinical Outcome Following Deep Vein Thrombosis
|
| Jalali F, Haghighi N, Swift P |
| |
|
Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study
|
| Simioni P, Rossetto V, Tognin G, Gavasso S, Fadin M, Perlati M, Castelli M, Tormene D, Pagnan A |
| |
|
Venous Thromboembolism after Spinal Cord Injury: Incidence, Time Course and Associated Risk Factors in 6240 Adults and Children
|
| White R, Jones T, Franks P, Ugalde V |
| |
|
Venous Thromboembolism and Spinal Surgery
|
| Pitham T, Cree A, Kam A, Dexter M, Dandie G, New C, Fearnside M, Cummine J, Hitos K, Saker K, Fletcher J |
| |
|
Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
|
| Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, Tormene D, Iotti M, Pesavento R, Iliceto S, Pagnan A, Girolami A, Lensing AWA |
| |
|
Venous Thromboembolism Following Total Hip or Knee Arthroplasty
|
| Hitos K, Fletcher JP |
| |
|
Venous Thromboembolism in 68 142 Patients with Colorectal Cancer
|
| White R, Alcalay A, Zhou H, Chew H, Harvey D, Wun T |
| |
|
Venous Thromboembolism in Heparin-Treated Patients: How Frequently Is It Associated with Heparin-Induced Thrombocytopenia?
|
| Levine RL, McCollum D, Hursting MJ |
| |
|
Venous Thromboembolism in Inflammatory Bowel Disease: The Pathogenetic Role of Tissue Factor Exposing Microparticles
|
| Weltermann A, Palkovits J, Kollars M, Hron G, Osterode W, Quehenberger P, Eichinger S, Kyrle PA, Novacek G |
| |
|
Venous Thromboembolism Occurs Commonly Out-Of-Hospital in Patients Recently Immobilized through Surgery or Illness: Findings from the VERITY Outpatient Treatment Registry
|
| O'Shaughnessy D, Rose P, Pressley F, Scriven N, Arya R, Amlot N |
| |
|
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units
|
| Tapson VF, Froehlich JB, Bergmann JF, Kakkar AK, Merli GJ, Piovella F, Spyropoulos AC, Zotz RB, FitzGerald G, Anderson Jr FA |
| |
|
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
|
| Zotz RB, Decousus H, Monreal M, Chong BH, Pavanello R, Pini M, Turpie AGG, Huang W, Anderson Jr FA |
| |
|
Venous Thromboembolism, Arterial Thrombosis and Plasma Homocysteine Levels in Families with Inherited Thrombophilia
|
| Domagala TB, Nizankowska E, Sanak M, Adamek L, Rzeszutko M, Szczeklik A |
| |
|
Venous Thromboembolism: Disease Burden, Outcomes and Risk Factors
|
| Heit JA |
| |
|
Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels
|
| Berger M, Kulle B, Schmidt H, Mattheisen M, Oldenburg J, Strauch K, Bickeböller H, Walter U, Lindner T, Schambeck C |
| |
|
Venous Thrombosis in Males Is Associated with Dyslipoproteinemia Involving High Density Lipoprotein (HDL) Deficiency and Excess Low Density Lipoprotein (LDL)
|
| Pecheniuk NM, Deguchi H, Elias DJ, Averell PM, Griffin JH |
| |
|
Venous Thrombosis in Women on Oral Contraceptives: A Study of 201 Cases
|
| Girolami A, Spiezia L, Sartori MT, Girolami B, Prandoni P |
| |
|
Verotoxin-1 Activation of the c-Yes in Human Monocytes/THP-1 Monocytic Cells Induces Tissue Factor Expression Through Activations of IKKbeta/NF-kappaB/Rel and ERK/Egr-1 Pathways
|
| Ishii H, Higuchi T, Takada K, Oida K |
| |
|
Video Enhanced Coagulation Assay (VECA) for Real Time Multi-Parameter Analysis of Blood Plasma Coagulation at Artificial Surfaces
|
| Faxälv L, Lindahl TL |
| |
|
Viral Respiratory Tract Infections Increase Platelet Reactivity and Activation – an Explanation for Higher Rates of MyocardialInfarction and Stroke during Viral Illness
|
| Kreutz R, Bliden K, Tantry U, Kreutz Y, Gurbel P |
| |
|
Viral Safety of a Novel von Willebrand Factor and Factor VIII Concentrate (Wilate®): Virus Inactivation Capacities of Optimised Solvent/Detergent and Terminal Dry-Heat Treatment
|
| Biesert L, Suhartono H, Klengel R, Schmidt T, Radomski KU, Schwarz G, Gruber G, Stadler M, Neisser-Svae A, Roemisch J, Svae TE |
| |
|
Viral Safety of a Prothrombin Complex Concentrate (Octaplex®): Combination of Solvent/Detergent (SD) Treatment with Nanofiltration
|
| Biesert L, Suhartono H, Klengel R, Schmidt T, Radomski KU, Franken T, Hoffer L |
| |
|
Visual Evidence How Histidine-Rich Glycoprotein Promotes Fibrinolysis
|
| Koide T, Fujimoto M |
| |
|
Visual Evidence How Histidine-Rich Glycoprotein Promotes Fibrinolysis
|
| Koide T, Fujimoto M |
| |
|
Visualization of Dynamic Fibrin Formation from APTT Recordings Reflects More Heterogeneity in Patients with Severe Haemophilia A Than Conventional APTT Values
|
| Sorensen B, Larsen LH, Andersen L, Johansen P, Hvitfeldt Poulsen L, Ingerslev J |
| |
|
Visualization of the Continuous APTT Coagulation Signature – Methods and Correlations to Continuous Thrombin Generation
|
| Sørensen B, Christiansen K, Andersen L, Larsen LH, Norengaard L, Hvitfeldt Poulsen L, Johansen P, Ingerslev J |
| |
|
Vitamin B6 Serum Level and Inflammation and in the InChianti Study
|
| Gori AM, Corsi AM, Bandinelli S, Giusti B, Lapini I, Lauretani F, Pepe G, Ferrucci L, Abbate R, Gensini GF |
| |
|
Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake
|
| Ampaiwan C, Tassanee P, Sassanee H, Praguywan K, Siwaporn S, Suthida C, Umaporn S, Yongyut H, Martin JS |
| |
|
von Willebrand Disease Type 2M: Laboratory and Molecular Studies. Results in One Single Centre
|
| Cid AR, Cabrera N, Casaña P, Haya S, Querol F, Aznar JA |
| |
|
von Willebrand Disease Type 2N (Normandy) in Three Siblings
|
| Pekcelen Y, Çaglayan H, Ayer M, Yavuz AS, Kalfa M |
| |
|
Von Willebrand Factor and ADAMTS-13 in 23 Doberman Pinschers Dogs
|
| Vera E, Krimer A, Farías C, Amaral M, Powazniak Y, Kempfer A, Lazzari M |
| |
|
von Willebrand Factor and Thrombomodulin in Patients with Thromboangiitis Obliterans
|
| Kloczko J, Terpilowski T, Galar M, Wronski J, Sokolowski J |
| |
|
von Willebrand Factor D'-D3-domains comprise an adhesion site for leukocytes
|
| Pendu R, Spijkers PP, Denis CV, de Groot PG, Lenting PJ |
| |
|
von Willebrand Factor in Platelets
|
| van Kraaij MGJ, Doornebal CW, van Haren BJT, Nováková IRO, van Heerde WL, Verbruggen H |
| |
|
von Willebrand Factor: Two Sides of a Coin
|
| Sadler JE |
| |
|
Von Willebrand Factor-Mediated Platelet Adhesion in Flowing Blood is Influenced by Hematocrit
|
| Machin M, Santomaso AC, Cozzi MR, Battiston M, Mazzucato M, De Marco L, Canu P |
| |
|
Von Willebrand Factor-mediated Sorting of Endothelial Secretory Proteins
|
| Bierings R, Sint R, Voorberg J, van Mourik JA |
| |
|
VWF1 Andvwf2 Alleles (Intron 40) Are Suitable Markers for Carrier Detection and Antenatal Diagnosis in VWD Families in Indian Population
|
| Shetty S, Trasi S, Ghosh K, Pathare A, Mohanty D |
| |
